This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Dyspareunia in females

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Dyspareunia or painful sex is a condition which presents as recurrent or persistent pain with sexual activity (1).

  • this is common but neglected problem causing distress, decreased sexual functioning and enjoyment, relationship difficulties and reduced quality of life (2)
  • it may be associate with or lead to other female sexual dysfunction disorders e.g. - decreased libido, decreased arousal, and anorgasmia (1)
  • population prevalence is estimated to vary from 3 to 18% globally, and lifetime estimates range from 10 to 28% (3)

Dyspareunia may be classified as:

  • superficial (entry) - pain confined to the introitus
  • deep - pain experienced deep in the pelvis during intercourse

or

  • primary – pain occurring since onset of sexual activity and thereafter
  • secondary – occurring after previous sexual activity that was not painful (1)

Significant risk factors and predictors for dyspareunia include:

  • younger age
  • education level below a college degree
  • urinary tract symptoms
  • poor to fair health
  • emotional problems or stress
  • a decrease in household income greater than 20% (1)
  • peri- or post-menopausal women

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.